Meiko Trans Co (9357) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Mar, 2026Executive summary
Net sales for the six months ended September 30, 2025, rose 0.9% year-over-year to ¥40,605 million.
Operating profit increased 7.8% year-over-year to ¥3,206 million, and ordinary profit rose 10.5% to ¥4,264 million.
Profit attributable to owners of parent grew 16.8% year-over-year to ¥2,899 million.
Comprehensive income surged 113.6% year-over-year to ¥6,166 million.
Financial highlights
Gross profit for the period was ¥8,909 million, up from ¥8,529 million year-over-year.
Basic earnings per share increased to ¥96.90 from ¥83.13 year-over-year.
Total assets as of September 30, 2025, were ¥161,255 million, up from ¥153,933 million at March 31, 2025.
Equity-to-asset ratio improved to 80.6% from 78.5% at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecast for fiscal year ending March 31, 2026, is ¥81,000 million, a 0.6% decrease year-over-year.
Operating profit is projected at ¥5,900 million, down 5.9% year-over-year.
Ordinary profit is forecast at ¥7,500 million, a 6.0% decrease, and profit attributable to owners of parent at ¥5,200 million, down 3.3%.
Annual dividend forecast is ¥70.00 per share, with a second quarter dividend of ¥35.00.
Latest events from Meiko Trans Co
- Sales and profits rose, but net income fell 6% year-over-year; outlook remains cautious.9357
Q1 202513 Mar 2026 - Profits and comprehensive income rose sharply, with improved outlook and higher dividends.9357
Q2 202513 Mar 2026 - Profits and dividends rose, but FY2026 forecasts slight declines in sales and profit.9357
Q4 202513 Mar 2026 - Profits rose on higher sales, but comprehensive income fell due to securities valuation losses.9357
Q3 202513 Mar 2026 - Strong quarterly profit growth, but full-year outlook signals lower earnings ahead.9357
Q1 202613 Mar 2026 - Profits and comprehensive income rose sharply, but full-year guidance signals a modest decline.9357
Q3 202613 Mar 2026